ACCUSOL

Brand name authorized in: Austria Spain France Ireland Poland United Kingdom

Active ingredients

The drug ACCUSOL contains a combination of these active pharmaceutical ingredients (APIs):

1 Calcium chloride dihydrate
UNII M4I0D6VV5M - CALCIUM CHLORIDE

Calcium is the most abundant mineral in the body, and is an essential body electrolyte. Homeostasis is mainly regulated by the parathyroid hormone, by calcitonin, and by the activated form of vitamin D. Calcium is a structural component of bones and teeth. It is also required for blood clotting, neurotransmitter release, muscle contraction and normal heartbeat.

Read about Calcium chloride
2 Magnesium chloride hexahydrate
UNII 02F3473H9O - MAGNESIUM CHLORIDE
Read about Magnesium chloride
3 Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

Read about Sodium chloride
4 Potassium chloride
UNII 660YQ98I10 - POTASSIUM CHLORIDE

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.

Read about Potassium chloride
5 Glucose monohydrate
UNII LX22YL083G - DEXTROSE MONOHYDRATE

Glucose is frequently used in both adults and children to restore blood glucose concentrations in the treatment of hypoglycaemia resulting from insulin excess or from other causes. The metabolism of glucose is an energy source for the body.

Read about Glucose
6 Sodium bicarbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE

Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide.

Read about Sodium bicarbonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Hemofiltrates
B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05Z Hemodialytics and hemofiltrates
Discover more medicines within B05ZB

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 67610, 67611, 67612
FR
Base de données publique des médicaments
Identifier(s): 61278936, 67627711, 69430342
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 400210, 400212